Insider Trading & Ownership of David C. Hastings

Location
Jersey City, NJ
Summary
The estimated net worth of David C. Hastings is at least $886,587 dollars as of 12 Jan 2026. David C. Hastings is the Chief Financial Officer of Arbutus Biopharma Corp and owns shares of Arbutus Biopharma Corp (ABUS) stock worth about $820.2K. David C. Hastings is the Director of SCYNEXIS INC and owns shares of SCYNEXIS INC (SCYX) stock worth about $66.4K.
Signature
/s/ Christopher Galletta, attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow David C. Hastings and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • David C. Hastings has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $886,587.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Arbutus Biopharma Corp ($820,172).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of David C. Hastings

SCYX Forms 3/4/5

SCYNEXIS INC

Relationship
Director
Holdings value
$66,415
Past year net change
Change %
Report period
26 Jun 2025

Insider Transactions Reported by David C. Hastings:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .